SCHEMBL11114541

SCHEMBL11114541

N#Cc1ccc(CC(C(=O)O)C(=O)O)c(Cl)c1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.48
P2RX7 Q99572 3/20 0.43
MRGPRX4 Q96LA9 2/20 0.41
PDK1 Q15118 1/20 0.41
PDK2 Q15119 1/20 0.41
PDK3 Q15120 1/20 0.41
PDK4 Q16654 1/20 0.41
FFAR1 O14842 1/20 0.39
HTT P42858 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
PTGDR2 Q9Y5Y4 1/20 0.39
VCAM1 P19320 1/20 0.38
FLT1 P17948 1/20 0.38
FLT4 P35916 1/20 0.38
KDR P35968 1/20 0.38
FOLH1 Q04609 1/20 0.38
EPHX2 P34913 2/20 0.38
GSK3B P49841 2/20 0.38
KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7768248 0.86 ALDH1A1 (0.45) ALDH1A1P2RX7NPSR1KMT2A
SCHEMBL25217534 0.86 ALDH1A1 (0.45) ALDH1A1P2RX7NPSR1KMT2A
SCHEMBL11116918 0.83 CYP3A4 (0.44) ALDH1A1P2RX7MRGPRX4PDK1PDK2
SCHEMBL14660970 0.80 ALDH1A1 (0.50) ALDH1A1P2RX7MRGPRX4PDK1PDK2
SCHEMBL30349567 0.80 ALDH1A1 (0.50) ALDH1A1P2RX7MRGPRX4PDK1PDK2
SCHEMBL5912933 0.80 PDK1 (0.44) ALDH1A1P2RX7MRGPRX4PDK1PDK2
SCHEMBL533893 0.79 P2RX7 (0.41) ALDH1A1P2RX7MRGPRX4PDK1PDK2
SCHEMBL13873028 0.78 NPC1 (0.41) ALDH1A1P2RX7PDK1PDK2PDK3
SCHEMBL11458388 0.78 IDO1 (0.49) ALDH1A1
SCHEMBL11112081 0.77 FFAR1 (0.51) ALDH1A1P2RX7MRGPRX4FFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0038071-B1 NEW UNLABELLED AND RADIOACTIVE LABELLED DERIVATIVES OF BUTYLAMINO PROPIOPHENONE, THEIR PREPARATION, IMMUNOGENS OBTAINED FROM THE UNLABELLED DERIVATIVES AND A PROCESS FOR IMMUNOGEN PREPARATION, ANTISERA RAISED USING THE IMMUNOGENS AND A METHOD FOR RAISING ANTISERA, A RADIOIMMUNOASSAY METHOD AND A TEST KIT FOR USE IN THE ASSAY METHOD THE WELLCOME FOUNDATION LIMITED (GB) 1984-11-14 EP disclosed